Biostate AI funding, investors and company details

Biostate AI is an emerging Healthcare startup from Bengaluru, working in the space of Biotech startup. Founded by David Zhang, Ashwin Gopinath.

Company: Bayosthiti Ai Private Limited
Sector: Healthcare
Location: Bengaluru
Founders: David Zhang, Ashwin Gopinath
Total funding raised: ₹102.64 Cr

Company overview

Biostate AI is a biotechnology company specializing in the development of advanced generative AI models that analyze large-scale omics datasets to predict health changes and disease progression. The company focuses on leveraging RNA sequencing (RNA-seq) technology combined with artificial intelligence to enable personalized medicine, by making diagnostics more affordable and accurate for conditions such as leukemia, coronary artery disease, and multiple sclerosis. Biostate AI has developed proprietary technologies that significantly reduce the cost of RNA sequencing to facilitate large-scale data collection and integration, aiming to transform clinical decision-making, drug development, and patient care. With partnerships spanning top medical research institutions and a global presence, Biostate AI strives to make healthcare more predictive and tailored to individual biology.

Funding rounds

Latest round (Series A): $ 12.00 Mn (₹102.64 Cr.), 2025-05-21. Investors: Accel